Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
12,401,280
-
Share change
-
+356,880
-
Total reported value
-
$87,176,074
-
Price per share
-
$7.03
-
Number of holders
-
60
-
Value change
-
+$1,872,295
-
Number of buys
-
43
-
Number of sells
-
21
Institutional Holders of RECRO PHARMA INC - COM (SCTL) as of Q2 2017
As of 30 Jun 2017,
RECRO PHARMA INC - COM (SCTL) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,401,280 shares.
The largest 10 holders included
Broadfin Capital, LLC, DEERFIELD MANAGEMENT CO, Stonepine Capital Management, LLC, BlackRock Inc., Alyeska Investment Group, L.P., VANGUARD GROUP INC, Cormorant Asset Management, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., OxFORD Asset Management LLP, and ACUTA CAPITAL PARTNERS, LLC.
This page lists
60
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.